See the DrugPatentWatch profile for zepbound
Does Zepbound Cause Heartburn?
Yes, heartburn is a reported side effect of Zepbound (tirzepatide), Eli Lilly's GLP-1/GIP receptor agonist for weight loss. Clinical trials showed gastrointestinal issues like heartburn (also called gastroesophageal reflux) in up to 5-10% of patients, often mild to moderate and decreasing over time.[1][2] It's linked to the drug's mechanism: slowing gastric emptying, which can relax the lower esophageal sphincter and allow stomach acid reflux.[3]
How Common Is Heartburn on Zepbound?
In SURMOUNT trials (phase 3 data for obesity), heartburn occurred in:
- 4.6% on 5 mg dose
- 6.2% on 10 mg
- 8.1% on 15 mg
Compared to 3.1% on placebo. Rates were higher early in treatment (first 4-12 weeks) and dropped with continued use. Women and those with prior GI issues reported it more.[1][4]
Why Does It Happen and When?
Zepbound mimics gut hormones to reduce appetite and delay digestion, leading to bloating, nausea, or reflux as side effects. Heartburn peaks after meals or doses, especially at higher doses (10-15 mg weekly). Risk factors include obesity itself (pre-existing reflux), fatty/spicy foods, or lying down soon after eating.[2][3]
How to Manage Heartburn While on Zepbound?
- Eat smaller, frequent meals; avoid triggers like caffeine, alcohol, chocolate.
- Stay upright 30-60 minutes post-meal; elevate bed head 6-8 inches.
- Over-the-counter antacids (e.g., Tums), H2 blockers (Pepcid), or PPIs (omeprazole) help most patients—discuss with doctor first.[2][5]
- Dose titration (starting low, increasing slowly) cuts incidence by 50%.[1] If severe, dose reduction or pause may be needed.
Does It Go Away, or Is It Permanent?
Most cases resolve within weeks as the body adjusts; only 1-2% discontinue due to persistent reflux. Long-term data (up to 72 weeks) shows sustained low rates.[1][4] Unlike some GLP-1s, Zepbound's dual action may cause less severe GI effects than semaglutide alone.[6]
Zepbound vs. Other Weight Loss Drugs for Heartburn
| Drug | Heartburn Rate (Trials) | Notes |
|------|--------------------------|-------|
| Zepbound (tirzepatide) | 5-8% | Dual hormone action; improves over time |
| Wegovy/Ozempic (semaglutide) | 5-7% | Similar profile, slightly higher nausea |
| Mounjaro (same as Zepbound, diabetes indication) | 5-9% | Identical drug; labeled for both uses |
| Saxenda (liraglutide) | 7-10% | Daily injection; more consistent GI upset |
Zepbound edges out single GLP-1s in tolerability for some.[6][7]
When to See a Doctor
Contact your provider if heartburn is severe, with vomiting blood, weight loss beyond expected, or chest pain (rule out heart issues). Rare cases link to gallbladder problems or esophagitis.[2][5] Not everyone gets it—20-30% report no GI effects.[1]
[1]: Zepbound Prescribing Information (FDA)
[2]: Eli Lilly SURMOUNT-1 Trial Data (NEJM)
[3]: Mechanism Review (Gastroenterology)
[4]: SURMOUNT Long-Term Safety (JAMA)
[5]: Mayo Clinic GLP-1 Side Effects Guide
[6]: Head-to-Head Comparison (Lancet)
[7]: Drugs.com User Reviews (Zepbound)